FDA — authorised 22 December 1997
- Marketing authorisation holder: ABBVIE
- Status: approved
FDA authorised Teveten on 22 December 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 December 1997.
ABBVIE holds the US marketing authorisation.